- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Latest Conference Articles
Keynote Session Highlights Importance of Process Validation and Data Integrity (INTERPHEX 2024)
April 17th 2024
Former FDA drug investigator, Daniel Roberts, discusses the importance of updating process validation and maintaining proper data integrity at a keynote session during INTERPHEX.
AES Clean Technology Launches CleanLock Module
April 16th 2024
The airlock solution for cleanrooms offers contamination controls for a highly controlled environment.
Bill Whitford of Arcadis Discusses 3D Printing for Biologics (INTERPHEX 2024)
April 16th 2024
At INTERPHEX, Bill Whitford, Strategic Solutions leader at Arcadis, discusses the progress made in 3D bioprinting toward commercial biologics production.
WMFTS Showcases New Single-Use Solutions Designed to Optimize Fluid Management
April 16th 2024
WMFTS has launched WMArchitect, a single-use product line that offers ready-to-use single-use assemblies and custom-designed workflows for biopharma fluid management.
A Look at New Airlift Technology in Single-Use Bioreactors Systems
December 11th 2023
Pharmaceutical Technology Europe® spoke with Fiona Bellot, sales director, Cellexus BioreactorSystems, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
Democratizing GMP Manufacturing for the New Therapeutic Pipeline
November 21st 2023
PharmTech Europe discusses technology that enables the “democratization” of mRNA manufacturing with Scott Ripley, general manager, Nucleic Acid Therapeutics and Precision Nanosystems, Cytiva, at the 11th International mRNA Health Conference in Berlin, Germany.
mRNA Advances Allow Drug Development Focus on Rare Diseases (Part Two)
November 20th 2023
In part two of an interview with Thomas Langenickel, MD, chief medical officer at Ethris, Langenickel highlights the challenges in developing mRNA therapeutics for pulmonary diseases.
Discussing the Origins of the mRNA Therapeutics Field (Part Two)
November 17th 2023
Andy Geall, co-founder and chief development officer at Replicate Bioscience continues the discussion on the development history of mRNA therapeutics.
mRNA Advances Allow Drug Development Focus on Rare Diseases (Part One)
November 14th 2023
A discussion with Thomas Langenickel, MD, chief medical officer at Ethris, shines a light on how advances made with mRNA technology are also advancing the industry’s ability to focus on treatment of rare diseases, such as rare lung diseases.
The Need for New Bioanalysis Technology (AAPS PharmSci 360)
November 7th 2023
Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation highlights the company’s motivation behind their new bioanalysis kit for oligonucleotides.